Wockhardt Limited (NSE:WOCKPHARMA)
1,479.40
+17.50 (1.20%)
Aug 22, 2025, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 240.39 billion as of August 22, 2025. Its market cap has increased by 84.84% in one year.
Market Cap
240.39B
Enterprise Value
258.42B
Revenue
30.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,479.40
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 240.39B, an increase of 1,281.26%. That is a compound annual growth rate of 11.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 240.39B | 4.43% |
Dec 31, 2024 | 230.20B | 276.45% |
Dec 29, 2023 | 61.15B | 90.30% |
Dec 30, 2022 | 32.13B | -29.77% |
Dec 31, 2021 | 45.75B | -24.44% |
Dec 31, 2020 | 60.55B | 133.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,939.23B |
Divi's Laboratories | 1,633.03B |
Cipla | 1,286.59B |
Apollo Hospitals Enterprise | 1,139.13B |
Mankind Pharma | 1,075.90B |
Zydus Lifesciences | 994.96B |
Fortis Healthcare | 705.43B |
Alkem Laboratories | 648.76B |